BOT vs IMR

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

BOT

BOTANIX FPO [BOT]

39LOW

IMR

IMRICOR CDI FORUS [IMR]

39LOW

Score Breakdown

BOT IMR
Technical
47
63
Catalyst
51
51
Sentiment
50
50
Fundamental
76
60
Momentum
29
58
Risk Gate
45
50

Key Metrics

BOT Metric IMR
$70.7MMarket Cap$625.5M
14.5MAvg Volume (20d)360K
+0.2%Short Interest+0.1%
$0.18052-Week High$2.250
$0.01852-Week Low$1.145
+0.0%Daily Change-3.8%
$0.025Reference Price$1.755
-121.1%ROE-1221.3%
N/AProfit MarginN/A

Active Signals

BOT Signals

●Stochastic is stretched into overbought — could need a breather
●Beating the Small Ords index — relative strength of 1.17, so it's outpacing the pack
●Below the 200-day average — the long-term trend is still working against it
●Critical cash runway (1.6 quarters)
●Low P/S ratio (3.2x)
●Strong revenue growth (+4271%)
●EPS estimates revised upward (+10pts)
●Near 52-week low (5% of range)

IMR Signals

●RSI drifting toward oversold territory — worth watching
●MACD momentum is losing steam
●Smart money may be accumulating — volume is flowing in even though price hasn't moved yet
●Sitting near support — this level has held before and could attract buyers again
●Drifting lower — down 3.8% over the last 5 days
●Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
●Trading above the 200-day average — the long-term trend is on your side
●Strong cash runway (9 quarters)

Ask Scout AI to compare BOT and IMR in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

IMR vs VHL →PKY vs RAC →BOT vs RAC →RAC vs VHL →EPN vs PKY →
BOT Full Analysis → IMR Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).